drugset / Trial / NCT05698550
The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
Completed
480 enrolled
Shandong University of Traditional Chinese Medicine
960th Hospital of Joint Logistics Support Force of People's Liberation Army of China · collabChongqing Medical Center for Women and Children · collabFirst Affiliated Hospital of Wenzhou Medical University · collabMaternal and Child Health Care Hospital of Shandong Province · collabMaternity and Child Health Care of Zaozhuang · collabShandong University · collabShanxi Provincial Maternity and Children's Hospital · collabThe Second Hospital of Hebei Medical University · collabYantai Shan Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This randomized controlled trial aims to determine whether Erzhi Tiangui Formula can optimize the reproductive outcomes of elderly patients with expected poor ovarian response, and to provide a new approach to traditional Chinese medicine assisted in vitro fertilization and embryo transfer (IVF-ET).
Timeline
- Start
- 2023-09-15
- Primary completion
- 2025-06-30
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erzhi Tiangui Granule | Unknown | 3 g | Oral |